MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 7, Issue 291, Pages 291ra95-291ra95
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-06-11
DOI
10.1126/scitranslmed.aaa4549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF- Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling
- (2014) B. C. Cooley et al. Science Translational Medicine
- Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury
- (2014) Piyushkumar Kapopara et al. THROMBOSIS AND HAEMOSTASIS
- Balancing Cationic and Hydrophobic Content of PEGylated siRNA Polyplexes Enhances Endosome Escape, Stability, Blood Circulation Time, and Bioactivity in Vivo
- (2013) Christopher E. Nelson et al. ACS Nano
- Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
- (2013) Brian C. Evans et al. Jove-Journal of Visualized Experiments
- The cyclic AMP response element-binding protein (CREB) mediates smooth muscle cell proliferation in response to angiotensin II
- (2013) Peter Molnar et al. Journal of Cell Communication and Signaling
- TLR 2 Induces Vascular Smooth Muscle Cell Migration Through cAMP Response Element−Binding Protein−Mediated Interleukin-6 Production
- (2012) Guan-Lin Lee et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia
- (2012) Keisuke Nakanishi et al. JOURNAL OF VASCULAR SURGERY
- The Intracellular Pharmacokinetics of Terminally Capped Peptides
- (2012) Ivo R. Ruttekolk et al. MOLECULAR PHARMACEUTICS
- Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo
- (2011) Akihito Muto et al. VASCULAR PHARMACOLOGY
- Intracellular Delivery of a Protein Antigen with an Endosomal-Releasing Polymer Enhances CD8 T-Cell Production and Prophylactic Vaccine Efficacy
- (2010) Suzanne Foster et al. BIOCONJUGATE CHEMISTRY
- Internalization and Intracellular Trafficking of a PTD-Conjugated Anti-Fibrotic Peptide, AZX100, in Human Dermal Keloid Fibroblasts
- (2010) Charles R. Flynn et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model
- (2010) Luciana B. Lopes et al. JOURNAL OF VASCULAR SURGERY
- Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce
- (2009) Brian Ward et al. JOURNAL OF PEPTIDE SCIENCE
- Role of heat shock protein 27 phosphorylation in migration of vascular smooth muscle cells
- (2009) Hai-Feng Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Intracellular Delivery of a Proapoptotic Peptide via Conjugation to a RAFT Synthesized Endosomolytic Polymer
- (2009) Craig L. Duvall et al. MOLECULAR PHARMACEUTICS
- Development of a novel endosomolytic diblock copolymer for siRNA delivery
- (2008) Anthony J. Convertine et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started